Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.

about

Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.

Item

http://www.wikidata.org/entity/Q50129848

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic value of metabolic ...... c patients with neuroblastoma.

@en

Prognostic value of metabolic ...... c patients with neuroblastoma.

@nl

type

Item

label

Prognostic value of metabolic ...... c patients with neuroblastoma.

@en

Prognostic value of metabolic ...... c patients with neuroblastoma.

@nl

prefLabel

Prognostic value of metabolic ...... c patients with neuroblastoma.

@en

Prognostic value of metabolic ...... c patients with neuroblastoma.

@nl

P1476

Prognostic value of metabolic ...... c patients with neuroblastoma.

@en

P2093

Chao Li

http://www.w3.org/2001/XMLSchema#string

Fengxian Zhang

http://www.w3.org/2001/XMLSchema#string

Hui Wang

http://www.w3.org/2001/XMLSchema#string

Jian Zhang

http://www.w3.org/2001/XMLSchema#string

Linlin Zhang

http://www.w3.org/2001/XMLSchema#string

Shuo Huang

http://www.w3.org/2001/XMLSchema#string

Shuqi Wu

http://www.w3.org/2001/XMLSchema#string

Suyun Chen

http://www.w3.org/2001/XMLSchema#string

P2860

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Neuroblastoma: biological insights into a clinical enigma.

Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.

Neuroblastoma: biology, prognosis, and treatment.

Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology.

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.

131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.

P2888

s00259-017-3851-9

P304

306-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-017-3851-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29110068

http://www.w3.org/2001/XMLSchema#string